AC
PAVMZ

Almitas Capital’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Almitas Capital’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-44,196
Closed -$27.8K – 100
2022
Q1 		$36K Buy
+44,196
New +$45.5K 0.02% 69

Other funds holding PAVMZ

WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Almitas Capital's PAVMZ Position: Q2 2022 in Review

Almitas Capital sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q2 2022, closing a stake of 44,196 shares — an estimated $27.8K sold.

Almitas Capital first reported a position in PAVMZ in Q1 2022 and held it in 1 quarter. The position peaked at $36K in Q1 2022. 7 funds tracked by Wall St. Rank hold PAVMZ as of Q2 2022.

  • Almitas Capital reported no remaining PAVmed Inc. Series Z Warrant position as of Q2 2022 after selling out during the quarter.
  • Almitas Capital sold 44,196 PAVmed Inc. Series Z Warrant shares in Q2 2022, an estimated $27.8K.
  • Almitas Capital first reported a position in PAVmed Inc. Series Z Warrant in Q1 2022 and held it in 1 quarter.
  • Almitas Capital's PAVmed Inc. Series Z Warrant position peaked at $36K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q2 2022.

Based on Almitas Capital's 13F filing for Q2 2022, filed 15 Aug 2022.